Silke Raffegerst

Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL

Daniel Nagel, Stefani Spranger, Michelle Vincendeau et al. · Cancer Cell · 2012 · 227 citations · Full text

Medicinal Chemistry, Biochemistry, Pharmacologic Inhibition +8

The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease

Zhen Su, Mario Peluso, Silke Raffegerst et al. · European Journal of Immunology · 2001 · 69 citations · Full text

Lymphoid Neoplasia, Lmp2a-specific Ctl, Lmp2a-specific Cytotoxic T +14

The CD6 Scavenger Receptor Is Differentially Expressed on a CD56<sup>dim</sup> Natural Killer Cell Subpopulation and Contributes to Natural Killer-Derived Cytokine and Chemokine Secretion

Monika Braun, Bernadette Müller, Dominik ter Meer et al. · Journal of Innate Immunity · 2010 · 60 citations

Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia

Sybille Regn, Silke Raffegerst, Hans‐Jochem Kolb et al. · British Journal of Haematology · 2000 · 56 citations

Hematological Malignancy, Ifn-alpha Therapy, Autoimmune Disease +14

Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant

Sybille Regn, Silke Raffegerst, Xian Chen et al. · Bone Marrow Transplantation · 2001 · 53 citations

Cell Therapy, Transplantation, Distinct Viruses +12